Journal Article

DZNE-2020-00384

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.

Singh, S. ; Nazabal, A. ; Kaniyappan, S.DZNE* ; Pellequer, J.-L. ; Wolberg, A. S. ; Imhof, D. ; Oldenburg, J. ; Biswas, A. (Corresponding author)

2019
MDPI Basel

This record in other databases:    

Please use a persistent id in citations: doi:10.3390/biom9120765

Abstract: Factor XIII (FXIII) is a predominant determinant of clot stability, strength, and composition. Plasma FXIII circulates as a pro-transglutaminase with two catalytic A subunits and two carrier-protective B subunits in a heterotetramer (FXIII-A2B2). FXIII-A2 and -B2 subunits are synthesized separately and then assembled in plasma. Following proteolytic activation by thrombin and calcium-mediated dissociation of the B subunits, activated FXIII (FXIIIa) covalently cross links fibrin, promoting clot stability. The zymogen and active states of the FXIII-A subunits have been structurally characterized; however, the structure of FXIII-B subunits and the FXIII-A2B2 complex have remained elusive. Using integrative hybrid approaches including atomic force microscopy, cross-linking mass spectrometry, and computational approaches, we have constructed the first all-atom model of the FXIII-A2B2 complex. We also used molecular dynamics simulations in combination with isothermal titration calorimetry to characterize FXIII-A2B2 assembly, activation, and dissociation. Our data reveal unequal pairing of individual subunit monomers in an otherwise symmetric complex, and suggest this unusual structure is critical for both assembly and activation of this complex. Our findings enhance understanding of mechanisms associating FXIII-A2B2 mutations with disease and have important implications for the rational design of molecules to alter FXIII assembly or activity to reduce bleeding and thrombotic complications.

Keyword(s): Calcium: pharmacology (MeSH) ; Factor XIII: chemistry (MeSH) ; HEK293 Cells (MeSH) ; Humans (MeSH) ; Molecular Docking Simulation (MeSH) ; Protein Conformation (MeSH) ; Protein Multimerization (MeSH) ; Protein Subunits: chemistry (MeSH) ; Thermodynamics (MeSH) ; Thrombin: pharmacology (MeSH)

---

Contributing Institute(s):

1. Cell and Animal Models of Neurodegeneration (AG Mandelkow 2)

Research Program(s):

1. 342 - Disease Mechanisms and Model Systems (POF3-342) (POF3-342)

Appears in the scientific report 2019

---

Database coverage:
; ; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Web of Science Core Collection

---